T15
Conclusion Neoadjuvant chemotherapy increases blood levels of circulating tumor cells, endothelial progenitor cells and mesenchymal stem cells progenitor fibroblasts, thus promoting the formation of premetastatic niche. The study was conducted with financial support from the Council for Grants of the President of the Russian Federation (Russia) for the state support of young philosophy doctors, agreements of SC 114.120.14.168-MD Russian Scientific Foundation (Russia), Grant No. 14-15-00318 (sample collection) and Russian Foundation for Basic Research (Russia), Grant No. 15-34-20864. We acknowledge support of this work by the Tomsk State University Competitiveness Improvement Program (Russia).
Source: European Journal of Cancer Supplements - Category: Cancer & Oncology Source Type: research
More News: Bone Marrow Aspiration and Biopsy | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Chemotherapy | Grants | HER2 | Men | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Stem Cell Therapy | Stem Cells | Study